🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

10300+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data

Showing 20 of 10300 recruiting trials

NARecruitingNCT07039201

A Study to Evaluate CG-102-12C in Glypican-3 (GPC3) Positive Advanced Hepatocellular Carcinoma (HCC)

🏥 Zhejiang University📍 2 sites📅 Started Jun 2025View details ↗
NARecruitingNCT07305337

Randomised Controlled Trial of Artificial Intelligence-assisted Health Education

👨‍⚕️ Fuling Fu Zhou, Zhongnan Hospital of Wuhan Universty📍 1 site📅 Started Jun 2025View details ↗
Phase 1RecruitingNCT07106749

CD180 CART for Relapsed or Refractory CD180 Positive Hematologic Malignancies

🏥 Institute of Hematology & Blood Diseases Hospital, China📍 1 site📅 Started Jun 2025View details ↗
Phase 2RecruitingNCT07079423

Teclistamab in Newly Diagnosed Mayo Stage IIIB AL Amyloidosis

🏥 Peking Union Medical College Hospital📍 1 site📅 Started Jun 2025View details ↗
NARecruitingNCT06118931

Time-restricted Eating, Window Timing, Type 2 Diabetes Status and Sex on Glycemic Control

👨‍⚕️ Amy A. Kirkham, PhD, University of Toronto📍 1 site📅 Started Jun 2025View details ↗
Phase 2RecruitingNCT07040956

A Clinical Trial Comparing Low-Dose RT + Targeted Therapy+ Immunotherapy vs Targeted Therapy+ Immunotherapy Alone as Neoadjuvant Therapy in Operable HNSCC Patients.

🏥 West China Hospital📍 1 site📅 Started Jun 2025View details ↗
Phase 1RecruitingNCT07027748

Feasibility Study of Prolonged Administration of Naxitamab, Irinotecan, and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma

👨‍⚕️ Steven DuBois, MD, MS, Dana-Farber Cancer Institute📍 2 sites📅 Started Jun 2025View details ↗
Phase 3RecruitingNCT06998524

A Study to Assess the Efficacy and Safety of Emicizumab in Participants With Type 3 Von Willebrand Disease

👨‍⚕️ Clinical Trials, Hoffmann-La Roche📍 27 sites📅 Started Jun 2025View details ↗
NAEnrolling by InvitationNCT07046832

Clinical Evaluation of an Augmented Reality Intraprocedural Needle Guidance Platform for Soft Tissue Biopsy

🏥 MediView XR, Inc.📍 3 sites📅 Started Jun 2025View details ↗
NARecruitingNCT06945042

ONC-LEUK-2406: The Impact of Systematic Financial Navigation in Acute Myeloid Leukemia

👨‍⚕️ Thomas Knight, MD, Wake Forest University Health Sciences📍 2 sites📅 Started Jun 2025View details ↗
EARLY_Phase 1RecruitingNCT07067905

Clinical Evaluation of [68Ga]Ga-XT771 PET for Diagnosis in Patients With Glioblastoma and Clear Cell Renal Cell Carcinoma

🏥 Chinese PLA General Hospital📍 1 site📅 Started Jun 2025View details ↗
Phase 1RecruitingNCT07087262

A Phase I Study of SNH-119014 in Healthy Volunteers

🏥 ScinnoHub Pharmaceutical Co., Ltd.📍 1 site📅 Started Jun 2025View details ↗
NARecruitingNCT06969833

Prospective Clinico-biological Database of Patients With Ovarian and/or Peritoneal and/or Fallopian Tube Carcinoma

🏥 Centre Oscar Lambret📍 1 site📅 Started Jun 2025View details ↗
Phase 2Enrolling by InvitationNCT06992440

Empagliflozin to Improve Right Ventricular Function in Pulmonary Arterial Hypertension

👨‍⚕️ Gustavo Heresi, MD, The Cleveland Clinic📍 3 sites📅 Started Jun 2025View details ↗
Phase 4RecruitingNCT06665997

Clinical and Biomarker Effects of Depot Medroxyprogesterone Acetate in Females With Sickle Cell Disease

👨‍⚕️ Andrea Roe, MD MPH, University of Pennsylvania📍 2 sites📅 Started Jun 2025View details ↗
Phase 3RecruitingNCT06973304

A Study of Teduglutide in Chinese Adults With Short Bowel Syndrome

👨‍⚕️ Study Director, Takeda📍 4 sites📅 Started Jun 2025View details ↗
RecruitingNCT06694363

New Biomarker-based Strategy to Screen and Monitor for Activated Phosphoinositide 3-kinase δ Syndrome

👨‍⚕️ Sven Kracker, PHD, Institut National de la Santé Et de la Recherche Médicale, France📍 7 sites📅 Started Jun 2025View details ↗
Phase 4RecruitingNCT06184659

Empirical Meropenem Versus Piperacillin/Tazobactam for Adult Patients With Sepsis

🏥 Scandinavian Critical Care Trials Group📍 2 sites📅 Started Jun 2025View details ↗
Phase 1RecruitingNCT07483827

A Clinical Trial to Test the Safety, Tolerability, and How the Body Processes CPV-104 in Healthy People and Patients With C3-Glomerulopathy

👨‍⚕️ Bernd Jilma, Prof., Medical University of Vienna📍 16 sites📅 Started Jun 2025View details ↗
Phase 1, PHASE2RecruitingNCT06826859

Daily Aspirin vs Split Dosing in High-risk Pregnancies (DASH)

🏥 Thomas Jefferson University📍 1 site📅 Started Jun 2025View details ↗
← PreviousPage 94 of 515Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →